In acute myeloid leukemia (AML), TP53INP2 is upregulated by FTO-mediated modification of m6A, which enhances autophagy activity by promoting the interaction of LC3 and ATG7, ultimately promoting leukemia cell survival [135]. This evidence concerns the gene MAP1LC3A and acute myeloid leukemia.